PRONAV Clinical

Executive Summary

PRONAV Clinical is a specialized service provider offering end-to-end supply chain solutions for clinical trials, targeting emerging pharmaceutical and biotechnology companies. Founded in 2018 and headquartered in Dublin, Ireland, the company focuses on delivering precision, speed, and on-time performance across the clinical supply continuum. Its services include consultative roadmapping, -80°C labeling, batch certification, and global distribution, effectively bridging the gap between manufacturing and clinical operations. By streamlining clinical trial supply chains, PRONAV aims to reduce delays and improve efficiency for its clients. The company operates in the medical devices and neuroscience sectors, reflecting a niche focus on high-stakes therapeutic areas. Despite being a private company without disclosed funding or valuation, PRONAV’s positioning in the growing clinical trial logistics market suggests potential for expansion. As emerging biotechs increasingly outsource supply chain management, PRONAV is well-placed to capture market share. However, the lack of public financials and limited visibility into its competitive moat warrant a moderate conviction. The company’s ability to secure repeat clients and expand geographically will be key to its growth trajectory.

Upcoming Catalysts (preview)

• Q4 2026Announcement of strategic partnership with a top-20 pharma company60% success
• Q3 2026Expansion into U.S. market with new facility or service hub70% success